EdgarLookup

Oruka Therapeutics, Inc. — 3 Filings

63 3 filings on record

This page lists all 3 filings submitted to the SEC by Oruka Therapeutics, Inc. (ORKA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Oruka Therapeutics, Inc. has filed 63 3 documents with the SEC since 2008. To view all SEC filings by Oruka Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-K405 10-Q 10-Q/A 144 3 3/A 4 4/A 424B2 424B3 424B4 424B5 425 5 8-A12G 8-K 8-K/A ARS CORRESP CT ORDER D DEF 14A DEFA14A EFFECT POS AM PRE 14A PRER14A RW S-1 S-1/A S-1MEF S-3 S-3/A S-3ASR S-3MEF S-4 S-4/A S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-25-000017 Dec 11, 2025
3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-012405 Jul 1, 2025
3 0001415889-25-005906 Feb 27, 2025 Feb 10, 2025
3 0001213900-24-076598 Sep 6, 2024 Aug 29, 2024
3 0001213900-24-076596 Sep 6, 2024 Aug 29, 2024
3 0001213900-24-076593 Sep 6, 2024 Aug 29, 2024
3 0001213900-24-076591 Sep 6, 2024 Aug 29, 2024
3 0001213900-24-076589 Sep 6, 2024 Aug 29, 2024
3 0001213900-24-076588 Sep 6, 2024 Aug 29, 2024
3 0001213900-24-076585 Sep 6, 2024 Aug 29, 2024
3 0001213900-24-076582 Sep 6, 2024 Aug 29, 2024
3 0001213900-24-076578 Sep 6, 2024 Aug 29, 2024
3 FORM 3 0001437749-24-022706 Jul 12, 2024 Jul 2, 2024
3 FORM 3 SUBMISSION 0001209191-22-061894 Dec 19, 2022 Dec 15, 2022
3 OWNERSHIP DOCUMENT 0000921895-22-002199 Jul 8, 2022 Jul 1, 2022
3 OWNERSHIP DOCUMENT 0000921895-22-002054 Jun 21, 2022 Jun 15, 2022
3 OWNERSHIP DOCUMENT 0000921895-22-001090 Apr 4, 2022 Apr 1, 2022
3 FORM 3 SUBMISSION 0001209191-21-031693 May 11, 2021 May 10, 2021
3 FORM 3 SUBMISSION 0001209191-17-012750 Feb 21, 2017 Feb 16, 2017
3 0001181431-15-008430 Jun 17, 2015 Jun 16, 2015
3 0001181431-15-008429 Jun 17, 2015 Jun 16, 2015
3 0001181431-15-008428 Jun 17, 2015 Jun 16, 2015
3 0001181431-15-008427 Jun 17, 2015 Jun 16, 2015
3 0001181431-15-008426 Jun 17, 2015 Jun 16, 2015
3 0001181431-15-008425 Jun 17, 2015 Jun 16, 2015
3 0001181431-15-008424 Jun 17, 2015 Jun 16, 2015
3 0001181431-15-008423 Jun 17, 2015 Jun 16, 2015
3 0001181431-15-008422 Jun 17, 2015 Jun 16, 2015
3 0001181431-15-008421 Jun 17, 2015 Jun 16, 2015
3 0001181431-15-008420 Jun 17, 2015 Jun 16, 2015
3 PRIMARY DOCUMENT 0001123292-15-000932 Jun 17, 2015 Jun 16, 2015
3 0001181431-15-008431 Jun 17, 2015 Jun 16, 2015
3 FORM 3 SUBMISSION 0001209191-14-078417 Dec 30, 2014
3 FORM 3 SUBMISSION 0001209191-14-078410 Dec 30, 2014
3 FORM 3 SUBMISSION 0001209191-14-010356 Feb 13, 2014 Feb 11, 2014
3 PRIMARY DOCUMENT 0001136261-13-000432 Oct 7, 2013 Sep 27, 2013
3 MAIN DOCUMENT DESCRIPTION 0001209191-13-043004 Sep 4, 2013 Sep 3, 2013
3 MAIN DOCUMENT DESCRIPTION 0001209191-13-038396 Jul 30, 2013 Jul 26, 2013
3 3 0001104659-12-073527 Nov 2, 2012 Oct 25, 2012
3 FORM 3 0001181431-09-056863 Dec 15, 2009 Dec 7, 2009
3 PRIMARY DOCUMENT 0001123292-09-000260 Mar 3, 2009 Feb 23, 2009
3 MAIN DOCUMENT DESCRIPTION 0001209191-09-006981 Feb 5, 2009 Jan 27, 2009
3 PRIMARY DOCUMENT 0001123292-09-000130 Feb 5, 2009 Jan 27, 2009
3 PRIMARY DOCUMENT 0001123292-09-000128 Feb 5, 2009 Jan 27, 2009
3 PRIMARY DOCUMENT 0001123292-09-000126 Feb 5, 2009 Jan 27, 2009
3 PRIMARY DOCUMENT 0001123292-09-000124 Feb 5, 2009 Jan 27, 2009
3 PRIMARY DOCUMENT 0001123292-09-000122 Feb 5, 2009 Jan 27, 2009
3 PRIMARY DOCUMENT 0001123292-09-000120 Feb 5, 2009 Jan 27, 2009
3 PRIMARY DOCUMENT 0001123292-09-000118 Feb 5, 2009 Jan 27, 2009
3 PRIMARY DOCUMENT 0001123292-09-000115 Feb 5, 2009 Jan 27, 2009